MedPath

Furosemide

Furosemide Tablets USP and Furosemide Oral Solution USPRx Only

Approved
Approval ID

a2e46e16-4adf-4599-b69d-a6f6f891ba75

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 31, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Furosemide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-6219
Application NumberNDA018823
Product Classification
M
Marketing Category
C73594
G
Generic Name
Furosemide
Product Specifications
Route of AdministrationORAL
Effective DateJuly 14, 2017
FDA Product Classification

INGREDIENTS (8)

FUROSEMIDEActive
Quantity: 20 mg in 1 1
Code: 7LXU5N7ZO5
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.